O4–01–07: Effects of FE65 and Dab–1 adaptor proteins on APP and ApoEr2 processing

G. William Rebeck, Laura A. Magill, Brian W. Howell, Hyang‐Sook HoeAlzheimer s & Dementia 2006 · DOI

Abstract

Trafficking and metabolism of APP, the precursor protein of the A–beta peptide, can be altered by its interaction with cytoplasmic adaptor proteins. Similarly, metabolism of receptors for ApoE, a genetic risk factor for Alzheimer disease, can be affected by many of the same adaptor proteins. We examine how two adaptor proteins, FE65 and Dab–1, affect APP and the ApoE receptor, ApoEr2. We use co–immunoprecipitation and immunohistochemistry to determine if proteins interact in primary neurons and transfected cells. We use western blot analyses to measure proteolytic fragments of APP and ApoEr2, and biotinylation to measure surface levels of APP and ApoEr2. Previous studies showed that FE65 interacts with APP via its C–terminal PTB domain. Co–immunoprecipitation experiments in transfected COS7 cells demonstrated an interaction between ApoEr2 and FE65 that depended on the FE65 N–terminal PTB domain. Full length FE65 increased co–immunoprecipitation of ApoEr2 and APP, suggesting the presence of a tripartite complex. FE65 also increased surface expression of ApoEr2. Constructs containing both FE65 PTB domains increased secreted APP, secreted ApoEr2, APP C–terminal fragments, and ApoEr2 C–terminal fragments, but constructs containing only a single PTB did not. Full–length FE65 decreased A–beta to a significantly greater extent than individual FE65 domains. We also examined the effect of the adaptor protein Dab–1 on APP and ApoEr2 processing. Dab–1 interacted with ApoEr2 and APP and increased levels of their secreted extracellular domains and cytoplasmic C–terminal fragments. These effects depended on the NPXY domains of APP and ApoEr2 and on the PTB domain of Dab–1, but did not depend on phosphorylation of Dab1. Dab1 decreased the APP beta–CTF and secreted A–beta levels. Full length Dab–1 and its PTB domain increased surface expression of ApoEr2 and APP. A ligand for ApoEr2, Reelin, significantly increased the interaction of ApoEr2 and Dab–1. Surprisingly, Reelin treatment also significantly increased the interaction of APP and Dab–1. FE65 can form an intracellular link between APP and ApoEr2 and affect the processing of each. Dab–1 also affects trafficking and processing of APP and ApoEr2, and these effects are altered by extracellular proteins.
BibTeX
@inproceedings{rebeck2006o,
  author = {G. William Rebeck and Laura A. Magill and Brian W. Howell and Hyang‐Sook Hoe},
  title = {{O4–01–07: Effects of FE65 and Dab–1 adaptor proteins on APP and ApoEr2 processing}},
  booktitle = {Alzheimer s \& Dementia},
  year = {2006},
  doi = {10.1016/j.jalz.2006.05.297},
}

Loading related content...

Figure